FB
Insider
Francesca Barone
Chief Scientific OfficerFrancesca Barone (Chief Scientific Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Candel Therapeutics, Inc. (CADL). The largest single filing was $236K of CADL (23,447 sh × $10.06, as filed), executed Jun 29.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$236K
shares × price, as filed
Last traded
Jun 29
Filed Jul 1
Median ADV $19.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $730K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
CADLRecent filings
CADLSALE
Candel Therapeutics, Inc.
View filing →
$236K23,447 sh × $10.06
Exec Jun 29
Filed Jul 1 · 4:22 PM ET CADLSALE Candel Therapeutics, Inc. View filing → $282K
32,146 sh × $8.76
Exec Mar 18 2025
Filed Mar 20 2025 · 5:30 PM ET CADLSALE Candel Therapeutics, Inc. View filing → $112K
13,673 sh × $8.22
Exec Jan 8 2025
Filed Jan 10 2025 · 5:30 PM ET CADLSALE Candel Therapeutics, Inc. View filing → $101K
22,081 sh × $4.56
Exec Nov 29 2024
Filed Dec 3 2024 · 5:30 PM ET